Rectal cancer is a common and serious disease in the Western hemisphere. Optimal
treatment of rectal cancer involves a multidisciplinary approach, with collaboration required …

The use of modern MRI technology in radiotherapy is fast growing. MRI is entering all facets
of radiotherapy. This review will start with a very short overview of the newest developments …

Purpose: To evaluate multiparametric MRI features in predicting pathologic response after
preoperative chemoradiation therapy (CRT) for locally advanced rectal cancer (LARC) …

The risk increases with age. Median age at diagnosis is about 70 years or slightly older in
most European countries. The literature on risk factors for colorectal cancer is extensive. Diet …

Dramatic improvements in the outcomes of patients with rectal cancer have occurred over
the past 30 years. Advances in surgical pathology, refinements in surgical techniques and …

This review summarizes current applications and clinical utility of diffusion-weighted imaging
(DWI) for rectal cancer and in addition provides a brief overview of more recent …

After neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer, 15–27% of
the patients experience a pathological complete response (pCR). This observation raises …

Background and purpose Diffusion-weighted imaging (DWI) for treatment response
monitoring is feasible on hybrid magnetic resonance linear accelerator (MR-linac) systems …

Aim Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for
locally advanced rectal cancer achieve a pathological complete response (p CR) while the …

MRI-guided radiotherapy systems have the potential to bring two important concepts in
modern radiotherapy together: adaptive radiotherapy and biological targeting. Based on …